Ticker,Title,Link
FULC,Fulcrum Therapeutics to Participate in Upcoming September Conferences,8/27/2024 10:05:00 PM
FULC,Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),8/23/2024 10:30:00 PM
FULC,Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief Commercial Officer and Heather Faulds as Chief Regulatory Affairs & Quality Assurance Officer,8/19/2024 1:00:00 PM
FULC,Stifel Nicolaus Keeps Their Buy Rating on Fulcrum Therapeutics (FULC),8/15/2024 12:17:44 PM
FULC,Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),8/9/2024 10:30:00 PM
FULC,"Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), Exact Sciences (EXAS) and Fulcrum Therapeutics (FULC)",8/5/2024 6:21:52 AM
FULC,Buy Rating Affirmed on Fulcrum Therapeutics Amid High Hopes for FSHD Treatment Success,8/1/2024 10:26:26 AM
FULC,Fulcrum Therapeutics: A Strong Buy on Accelerated Clinical Progress and Strategic Focus,7/31/2024 4:05:53 PM
FULC,Fulcrum Therapeutics Q2 2024 Earnings Preview,7/30/2024 4:34:17 PM
FULC,"Fulcrum Therapeutics to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, July 31, 2024, at 8:00 a.m. ET",7/24/2024 2:00:00 PM
FULC,Fulcrum Therapeutics (FULC) Receives a Buy from Piper Sandler,7/19/2024 10:47:35 AM
FULC,Fulcrum Therapeutics to Present at the 31st Annual FSHD Society International Research Congress,6/12/2024 2:00:00 PM
FULC,Fulcrum Therapeutics to Participate in the Goldman Sachs’ 45th Annual Global Healthcare Conference,6/6/2024 2:00:00 PM
FULC,Goldman Sachs Predicts up to 108% Rally for These 2 ‘Strong Buy’ Stocks,5/26/2024 10:02:13 AM
FULC,Buy Rating Reaffirmed for Fulcrum Therapeutics Amid Sanofi Partnership and Promising Drug Prospects,5/16/2024 8:08:29 AM
FULC,RBC Capital Keeps Their Buy Rating on Fulcrum Therapeutics (FULC),5/14/2024 11:17:49 AM
FULC,Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings),5/13/2024 11:01:14 PM
FULC,Here's what to expect from Fulcrum Therapeutics's earnings,5/12/2024 3:01:13 PM
FULC,Fulcrum Therapeutics to Participate in Upcoming May Conferences,5/9/2024 2:00:00 PM
FULC,Fulcrum Therapeutics Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral muscular dystrophy (ReDUX4) in The Lancet Neurology,5/8/2024 2:00:00 PM
FULC,"Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8:00 a.m. ET",5/6/2024 2:00:00 PM
FULC,Biotech on a Budget: 7 Stocks Under $10 With Huge Potential,4/15/2024 4:54:18 PM
FULC,Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium,3/28/2024 9:05:00 PM
FULC,Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),3/22/2024 9:30:00 PM
FULC,"Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT), Fulcrum Therapeutics (FULC) and AC Immune SA (ACIU)",3/19/2024 5:50:30 AM
FULC,Fulcrum Therapeutics appoints Patrick Horn as permanent Chief Medical Officer,3/18/2024 12:02:15 PM
FULC,Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),3/8/2024 10:30:00 PM
FULC,Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,3/6/2024 7:54:52 PM
FULC,Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference,3/5/2024 2:00:00 PM
FULC,Strong Buy Rating for Fulcrum Therapeutics Amidst Promising Clinical Progress and Financial Stability,3/1/2024 6:04:47 AM
FULC,Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings),2/28/2024 9:00:52 PM
FULC,Fulcrum Therapeutics files for $350M mixed shelf,2/27/2024 10:28:55 PM
FULC,Fulcrum Therapeutics Q4 2023 Earnings Preview,2/26/2024 5:41:29 PM
FULC,"Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on Tuesday, February 27, 2024, at 8:00 a.m. ET",2/20/2024 10:01:00 PM
FULC,Stifel Nicolaus Sticks to Their Buy Rating for Fulcrum Therapeutics (FULC),2/9/2024 1:29:42 PM
FULC,Fulcrum Therapeutics to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference,2/6/2024 2:00:00 PM
FULC,Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session,12/22/2023 7:28:37 PM
FULC,Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),12/7/2023 10:30:00 PM
FULC,Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),11/10/2023 10:30:00 PM
FULC,Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences,11/9/2023 2:00:00 PM
FULC,Potential Upside for Fulcrum Therapeutics: Buy Rating Reiterated Based on Progress in FSHD Therapy and Promising REACH Study Outcomes,11/8/2023 11:36:37 AM
FULC,Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2023,11/7/2023 1:00:00 PM
FULC,What Wall Street expects from Fulcrum Therapeutics's earnings,11/6/2023 3:01:14 PM
FULC,"Fulcrum Therapeutics to Host Third Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023, at 8:00 a.m. ET",10/31/2023 1:50:33 PM
FULC,"Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023",9/25/2023 5:00:37 PM
FULC,Fulcrum Therapeutics to Participate at the Cantor Fitzgerald Global Healthcare Conference,9/22/2023 2:00:00 PM
FULC,Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),9/15/2023 10:30:00 PM
FULC,"GRAB, DHC and ADPT are among after hour movers",9/12/2023 9:27:39 PM
FULC,Fulcrum Announces Completion of Enrollment in the Phase 3 REACH Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD),9/7/2023 2:00:00 PM
FULC,"MVIS, DHC and RUM are among after hour movers",8/28/2023 9:17:30 PM
FULC,Why Splunk Are Trading Higher By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,8/24/2023 7:22:18 PM
FULC,Fulcrum Therapeutics To Rally Around 120%? FDA Update Removes Overhang On Pivotal Program,8/23/2023 8:31:46 PM
FULC,Crude Oil Falls; Dick's Sporting Goods Earnings Miss Views,8/22/2023 9:07:14 PM
FULC,Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),8/11/2023 10:53:28 PM
FULC,H.C. Wainwright Sticks to Their Hold Rating for Fulcrum Therapeutics (FULC),8/4/2023 10:35:44 AM
FULC,"Fulcrum Therapeutics GAAP EPS of -$0.38 beats by $0.06, revenue of $0.9M misses by $0.06M",8/3/2023 2:18:52 PM
FULC,Fulcrum Therapeutics earnings preview: what to expect,8/2/2023 3:01:13 PM
FULC,Fulcrum inks licensing deal for rare blood disorder,7/10/2023 1:26:42 PM
FULC,"FULC DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important June 27 Deadline in Securities Class Action - FULC",6/25/2023 5:00:00 PM
FULC,"ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important June 27 Deadline in Securities Class Action - FULC",6/17/2023 8:00:00 PM
FULC,"ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FULC",6/13/2023 3:00:00 AM
FULC,Fulcrum Therapeutics (FULC) Receives a Hold from Stifel Nicolaus,6/7/2023 2:07:33 AM
FULC,"FULC INVESTOR NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FULC",6/3/2023 4:15:00 AM
FULC,Fulcrum Therapeutics (FULC) Gets a Hold from Stifel Nicolaus,5/30/2023 2:07:33 AM
FULC,"ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FULC",5/27/2023 4:29:00 AM
FULC,Stifel Nicolaus Sticks to Their Hold Rating for Fulcrum Therapeutics (FULC),5/25/2023 2:07:44 AM
FULC,"Analysts’ Top Healthcare Picks: Fulcrum Therapeutics (FULC), Xeris Pharmaceuticals (XERS)",5/21/2023 1:30:30 PM
FULC,H.C. Wainwright Remains a Hold on Fulcrum Therapeutics (FULC),5/16/2023 10:25:17 AM
FULC,Goldman Sachs Reaffirms Their Hold Rating on Fulcrum Therapeutics (FULC),5/15/2023 9:45:32 PM
FULC,What Wall Street expects from Fulcrum Therapeutics's earnings,5/14/2023 3:01:13 PM
FULC,"ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Fulcrum Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FULC",5/12/2023 9:11:00 PM
FULC,"Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023",5/4/2023 5:00:45 PM
FULC,Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month,4/13/2023 2:59:53 PM
FULC,"SOFI,PENN and FYBR are among after hour movers",4/11/2023 9:33:17 PM
FULC,"ADMA, AMTX and SGH are among after hour movers",4/6/2023 9:02:48 PM
FULC,Fulcrum Therapeutics CFO resigns,4/5/2023 12:21:23 PM
FULC,"VRNA, ACCD and SLGC are among after hour movers",4/4/2023 9:08:18 PM
FULC,"Catalyst watch: Spotlight on the Fed meeting, Nvidia, Nike And Foot Locker",3/17/2023 7:00:22 PM
FULC,"Analysts Offer Insights on Healthcare Companies: DarioHealth (DRIO), Fulcrum Therapeutics (FULC) and Black Diamond Therapeutics (BDTX)",3/14/2023 2:10:21 AM
FULC,"Analysts’ Top Healthcare Picks: Fulcrum Therapeutics (FULC), Galecto (GLTO)",3/10/2023 9:20:15 PM
FULC,Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,3/9/2023 7:10:33 PM
FULC,"VOD, ACAD and BLUE are among after hour movers",3/6/2023 10:01:40 PM
FULC,Fulcrum Therapeutics (FULC) Receives a Buy from SVB Securities,3/1/2023 4:55:21 AM
FULC,"Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023",2/28/2023 4:00:37 PM
FULC,What 6 Analyst Ratings Have To Say About Fulcrum Therapeutics,2/27/2023 8:00:57 PM
FULC,Dow Dips 350 Points; S&P 500 Down Over 1%,2/24/2023 8:35:02 PM
FULC,$30M Bet On Deciphera Pharmaceuticals? Check Out These 4 Stocks Insiders Are Buying,1/25/2023 12:48:10 PM
FULC,Morgan Stanley Keeps Their Buy Rating on Fulcrum Therapeutics (FULC),1/24/2023 4:26:39 PM
FULC,Analysts Have Conflicting Sentiments on These Healthcare Companies: Concert Pharma (CNCE) and Fulcrum Therapeutics (FULC),1/19/2023 4:40:10 PM
FULC,Why Fulcrum Therapeutics Shares Are Falling,1/18/2023 3:18:12 PM
FULC,Fulcrum Therapeutics commences $100M underwritten public offering of shares,1/17/2023 9:08:55 PM
FULC,"Analysts Offer Insights on Healthcare Companies: InMode (INMD), Fulcrum Therapeutics (FULC) and Amarin (AMRN)",1/16/2023 5:20:21 AM
FULC,$3.4 Million Bet On CrowdStrike Holdings? Check Out These 3 Stocks Insiders Are Buying,1/9/2023 3:17:48 PM
FULC,SVB Securities Remains a Buy on Fulcrum Therapeutics (FULC),1/6/2023 5:15:17 AM
FULC,Fulcrum Therapeutics Names Robert Gould As Interim CEO After CEO Bryan Stuart Departs ,1/4/2023 1:22:01 PM
FULC,Over $13 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying,12/19/2022 3:01:01 PM
FULC,"FULC, CMBM: 2 Underdog Stocks Analysts are Recommending Right Now",11/16/2022 12:11:50 AM
FULC,"BZUN,AVPT and DOMO are among after hour movers",11/15/2022 11:06:07 PM
FULC,Morgan Stanley Sticks to Their Buy Rating for Fulcrum Therapeutics (FULC),11/14/2022 4:35:39 PM
FULC,Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),11/12/2022 12:33:20 AM
FULC,SVB Securities Reaffirms Their Buy Rating on Fulcrum Therapeutics (FULC),11/10/2022 4:35:11 AM
FULC,H.C. Wainwright Reaffirms Their Buy Rating on Fulcrum Therapeutics (FULC),11/9/2022 11:25:22 AM
FULC,Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results,11/8/2022 1:17:58 PM
FULC,Fulcrum Therapeutics Appoints Chief Medical Officer and Chief Scientific Officer,11/7/2022 11:00:00 PM
FULC,"Fulcrum Therapeutics® to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Tuesday, November 8, 2022 at 8:00 a.m. ET",11/2/2022 12:05:00 PM
FULC,Fulcrum Therapeutics® to Participate at Upcoming November Investor Conferences,11/1/2022 10:29:02 PM
FULC,Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday,10/21/2022 10:36:56 AM
FULC,Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session,10/20/2022 7:17:05 PM
FULC,"ABUS, EHTH and CDNA are among after hour movers",10/19/2022 9:29:45 PM
FULC,"Fulcrum Therapeutics to Present New Data from the Open Label Extension of Phase 2 ReDUX4 Study at the World Muscle Society (WMS) Congress in Halifax, Canada",10/12/2022 1:30:00 PM
FULC,Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),10/7/2022 11:00:00 PM
FULC,Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),9/9/2022 11:00:00 PM
FULC,Fulcrum Therapeutics to Participate at Upcoming September Investor Conferences,9/6/2022 10:01:00 PM
FULC,"Artelo, Ventyx top healthcare gainers; Albireo, Sema4 lead losers' pack",8/16/2022 2:03:11 PM
FULC,Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock,8/15/2022 10:08:06 PM
FULC,Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update,8/11/2022 1:00:00 PM
FULC,Fulcrum Therapeutics earnings preview: what Wall Street is expecting,8/10/2022 3:01:13 PM
FULC,"Fulcrum Therapeutics® to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 11, 2022 at 8:00 a.m. ET",8/4/2022 2:07:41 PM
FULC,Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),8/2/2022 2:00:00 PM
FULC,Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),7/15/2022 2:00:00 PM
FULC,Fulcrum Therapeutics Announces Departure of Chief Medical Officer,7/11/2022 11:00:00 PM
FULC,Fulcrum begins dosing in late-stage study of losmapimod for rare muscle disorder,7/5/2022 5:45:33 PM
FULC,4 Analysts Have This to Say About Fulcrum Therapeutics,6/13/2022 3:12:31 PM
FULC,Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),6/10/2022 10:02:00 PM
FULC,Fulcrum gains as Merck ends deal for lung disease candidates,6/7/2022 5:03:19 PM
FULC,Analyst Ratings for Fulcrum Therapeutics,5/17/2022 3:12:32 PM
FULC,"Fulcrum Therapeutics to Present Initial Data from Phase 1b Trial of FTX-6058 in Adults Living with Sickle Cell Disease at the European Hematology Association (EHA) Hybrid Congress in Vienna, Austria",5/12/2022 11:08:53 PM
FULC,Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results,5/9/2022 1:00:00 PM
FULC,What Wall Street expects from Fulcrum Therapeutics's earnings,5/8/2022 3:01:13 PM
FULC,Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),5/6/2022 2:00:00 PM
FULC,Fulcrum Therapeutics to Participate at the Upcoming BofA Securities 2022 Healthcare Conference,5/5/2022 2:00:00 PM
FULC,"Fulcrum Therapeutics to Host First Quarter 2022 Financial Results Conference Call and Webcast on Monday, May 9, 2022 at 8:00 a.m. ET",5/2/2022 2:00:00 PM
FULC,"ATER, HNRG and AGLE among mid-day movers",4/13/2022 4:55:45 PM
FULC,Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),4/8/2022 2:00:00 PM
FULC,"The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel",4/5/2022 1:48:52 PM
FULC,"The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight",4/3/2022 11:32:49 PM
FULC,Fulcrum Therapeutics® Announces Multiple Presentations on FSHD at the American Academy of Neurology’s Annual Meeting,4/1/2022 2:30:00 PM
FULC,Fulcrum Therapeutics® to Host Virtual Key Opinion Leader Webcast Featuring Losmapimod for Facioscapulohumeral Muscular Dystrophy (FSHD),3/17/2022 1:00:00 PM
FULC,Fulcrum Therapeutics® Presents Data Highlighting Reachable Workspace (RWS) as Relevant Functional Endpoint in Facioscapulohumeral Muscular Dystrophy (FSHD) at MDA Clinical and Scientific Conference,3/14/2022 1:00:00 PM
FULC,Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),3/11/2022 2:00:00 PM
FULC,Fulcrum rises as Oppenheimer highlights sickle cell disease candidate,3/8/2022 6:01:10 PM
FULC,Fulcrum Therapeutics To Start Late-Stage Losmapimod Trial In Rare Muscle Wasting Disorder,3/3/2022 5:24:33 PM
FULC,Fulcrum Therapeutics is about to announce its earnings — here's what Wall Street expects,3/2/2022 3:01:13 PM
FULC,"The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight",2/27/2022 3:26:47 PM
FULC,"Fulcrum Therapeutics® to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast on Thursday, March 3, 2022 at 8:00 a.m. ET",2/24/2022 2:00:00 PM
FULC,Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),2/11/2022 2:00:00 PM
FULC,Fulcrum Therapeutics® to Participate in 11th Annual SVB Leerink Global Healthcare Conference,2/10/2022 2:00:00 PM
FULC,Fulcrum Therapeutics® Announces Upcoming Milestones to Support Its Mission of Treating the Root Cause of Rare Genetic Diseases,1/10/2022 1:00:00 PM
FULC,Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),1/7/2022 2:00:00 PM
FULC,Fulcrum Therapeutics® to Present at the 40th Annual J.P. Morgan Healthcare Conference,1/6/2022 2:00:00 PM
FULC,Fulcrum Therapeutics® Appoints Esther Rajavelu as Chief Financial Officer,1/4/2022 2:00:00 PM
FULC,Fulcrum Therapeutics Shares Additional Data From Phase 1 Trial Of Sickle Cell Disease Treatment,12/6/2021 3:35:03 PM
FULC,Fulcrum Therapeutics® Appoints Sonja L. Banks to its Board of Directors,11/17/2021 2:00:00 PM
FULC,"The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO",11/4/2021 1:14:49 PM
FULC,Fulcrum Therapeutics is about to announce its earnings — here's what Wall Street expects,11/3/2021 3:01:13 PM
FULC,"The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline",10/31/2021 7:23:54 PM
FULC,"Fulcrum Therapeutics™ to Host Third Quarter 2021 Financial Results Conference Call and Webcast on Thursday, November 4, 2021 at 8:00 a.m. ET",10/28/2021 1:00:00 PM
FULC,Fulcrum Therapeutics™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),10/1/2021 1:00:00 PM
FULC,"The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs",9/22/2021 1:45:28 PM
FULC,"The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data",9/21/2021 2:20:50 PM
FULC,Fulcrum Therapeutics™ Announces Multiple Presentations During the Virtual Congress of the World Muscle Society,9/20/2021 1:00:00 PM
FULC,"Cramer Weighs In On Lennar, Alibaba And More",9/15/2021 1:10:54 PM
FULC,Fulcrum Therapeutics™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),9/10/2021 1:00:00 PM
FULC,Fulcrum Therapeutics™ Appoints Mel Hayes as Chief Commercial Officer,9/8/2021 1:00:00 PM
FULC,"The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab",9/2/2021 2:19:58 PM
FULC,"The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering",9/1/2021 1:32:13 PM
FULC,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration",8/27/2021 1:35:25 PM
FULC,"The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO",8/26/2021 2:09:14 PM
FULC,"The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal",8/24/2021 2:09:21 PM
FULC,10 Biggest Price Target Changes For Tuesday,8/17/2021 1:56:45 PM
FULC,Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares,8/16/2021 10:01:00 PM
FULC,"The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow",8/15/2021 5:06:13 PM
FULC,"Fulcrum stock leads weekly healthcare gainers; Axsome, Sesen Bio among laggards",8/14/2021 6:28:26 PM
FULC,Mid-Afternoon Market Update: Dow Drops 50 Points; IEC Electronics Shares Spike Higher,8/12/2021 8:46:48 PM
FULC,48 Stocks Moving In Wednesday's Mid-Day Session,8/11/2021 6:03:49 PM
FULC,Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock,8/10/2021 10:24:01 PM
FULC,"The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight",8/8/2021 4:11:24 PM
FULC,"Fulcrum Therapeutics to Host Second Quarter 2021 Financial Results Conference Call and Webcast on Tuesday, August 10, 2021 at 8:00 a.m. ET",8/4/2021 1:00:00 PM
FULC,"The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs",6/30/2021 1:28:56 PM
FULC,"MRIN, ALT, FLXN and FULC among after-hours movers",6/29/2021 9:50:57 PM
FULC,"Stifel nearly doubles Fulcrum price target, assumes 354% upside",6/24/2021 4:43:46 PM
FULC,Fulcrum Therapeutics Announces Multiple Presentations at the 28th Annual FSHD Society International Research Congress (IRC),6/21/2021 1:00:00 PM
FULC,"The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs",6/20/2021 4:04:37 PM
FULC,"Fulcrum Therapeutics, Evofem Biosciences Drug Candidates Receive FDA Fast Track Designation",5/12/2021 10:19:27 PM
FULC,Fulcrum Therapeutics to Present at the BofA Securities 2021 Virtual Health Care Conference,5/7/2021 1:00:00 PM
FULC,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom",5/6/2021 1:49:39 PM
FULC,"Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge",5/1/2021 7:19:25 PM
FULC,"Fulcrum Therapeutics to Host First Quarter 2021 Financial Results Conference Call and Webcast on Thursday, May 6, 2021 at 8:00 a.m. ET",4/29/2021 1:00:00 PM
FULC,Fulcrum Therapeutics Presents Published Structure of Investigational Small Molecule FTX-6058 at the American Chemical Society (ACS) Spring 2021 Virtual Conference,4/9/2021 7:15:00 PM
FULC,"Fulcrum Therapeutics Appoints Judith A. Dunn, Ph.D. as President of Research and Development",3/24/2021 2:29:00 PM
FULC,"Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2021",3/22/2021 3:42:59 PM
FULC,Fulcrum Therapeutics Presents Data for Potential FSHD Biomarker and Clinical Outcome Assessments at 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference,3/18/2021 4:30:00 PM
FULC,Fulcrum Therapeutics halts COVID-19 trial; names new CEO,3/4/2021 4:48:34 PM
FULC,"Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, March 4, 2021 at 8:00 a.m. ET",2/26/2021 1:00:00 PM
FULC,Fulcrum Therapeutics to Participate in Upcoming Investor Conferences,2/19/2021 1:00:00 PM
FULC,Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to  Purchase Additional Shares,1/22/2021 10:00:00 PM
FULC,68 Biggest Movers From Yesterday,1/21/2021 11:03:58 AM
FULC,Fulcrum Therapeutics prices equity offering at $11,1/20/2021 4:50:45 AM
FULC,Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock,1/19/2021 10:01:00 PM
FULC,Fulcrum Therapeutics to Participate in the H.C. Wainwright BioConnect 2021 Conference,1/6/2021 1:00:00 PM
FULC,Fulcrum Therapeutics to Host Virtual Key Opinion Leader Event Featuring FTX-6058 for Sickle Cell Disease,12/9/2020 1:00:00 PM
FULC,Fulcrum Therapeutics Presents Updated Data on Sickle Cell Disease Program at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition,12/5/2020 4:00:00 PM
FULC,Seeking Alpha Catalyst Watch,11/20/2020 8:30:48 PM
FULC,Fulcrum Therapeutics to Participate in Upcoming Investor Conferences,11/13/2020 1:30:00 PM
FULC,Fulcrum Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results,11/10/2020 1:00:00 PM
FULC,Fulcrum Therapeutics Announces Multiple Presentations During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition,11/4/2020 10:01:00 PM
FULC,"Fulcrum Therapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, November 10, 2020 at 8:00 a.m. ET",11/3/2020 1:00:00 PM
FULC,Fulcrum Therapeutics to Initiate Phase 1 Trial with FTX-6058 for Sickle Cell Disease,10/5/2020 1:00:10 PM
FULC,Fulcrum Therapeutics Announces Multiple Presentations During the Virtual 25th International Congress  of the World Muscle Society,10/1/2020 1:00:10 PM
FULC,Fulcrum Therapeutics Announces Preclinical Proof-of-Concept Data for FTX-6058 at the Virtual 14th Annual Sickle Cell Disease Research & Educational Symposium and  43rd National Sickle Cell Disease...,9/25/2020 8:15:10 PM
FULC,Fulcrum Therapeutics to Participate in Upcoming Investor Conferences,9/8/2020 1:00:10 PM
FULC,Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results,8/11/2020 1:01:10 PM
FULC,Fulcrum Therapeutics to Participate in Upcoming Investor Conferences,8/6/2020 1:00:10 PM
FULC,"Fulcrum Therapeutics to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, August 11, 2020 at 8:00 a.m. ET",8/5/2020 1:00:10 PM
FULC,MyoKardia and Fulcrum Therapeutics Announce Multi-Target Collaboration to Discover Novel Targeted Therapies for Genetic Cardiomyopathies,7/21/2020 1:30:10 PM
FULC,Fulcrum Therapeutics Announces Initiation of Multi-Center Phase 3 (LOSVID) Trial with Losmapimod for Hospitalized COVID-19 Patients,6/24/2020 1:00:10 PM
FULC,Fulcrum Therapeutics Completes $68.5 Million Private Placement,6/10/2020 1:01:10 PM
FULC,Fulcrum Therapeutics Announces Multiple Presentations at the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Platform,5/21/2020 1:00:10 PM
FULC,Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results,5/13/2020 1:00:10 PM
FULC,Fulcrum Therapeutics to Present at the BofA Securities 2020 Health Care Conference,5/11/2020 1:00:10 PM
FULC,"Fulcrum Therapeutics to Host First Quarter 2020 Financial Results Conference Call and Webcast on Wednesday, May 13, 2020 at 8:00 a.m. ET",5/7/2020 1:00:10 PM
FULC,Fulcrum Therapeutics Announces Completion of IND-enabling Safety Studies for FTX-6058 in Sickle Cell Disease,4/13/2020 1:00:10 PM
FULC,Fulcrum Therapeutics Provides Business Update on Impact of COVID-19,4/2/2020 1:00:00 PM
FULC,Fulcrum Therapeutics Announces Complete Data from Phase 1 Trial with Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD),3/24/2020 7:20:00 PM
FULC,OpGen leads healthcare gainers; Tetraphase Pharmaceuticals tops the losers,3/16/2020 3:01:04 PM
FULC,Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2019 Financial Results,3/5/2020 1:00:00 PM
FULC,Fulcrum Therapeutics Joins in Effort to “Reframe Rare” to Commemorate Rare Disease Day 2020,2/28/2020 1:00:00 PM
FULC,Fulcrum Therapeutics Announces Completion of Enrollment in Phase 2b Trial of Losmapimod for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD),2/26/2020 1:00:00 PM
FULC,"Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast on Thursday, March 5, 2020 at 8:00 a.m. ET",2/25/2020 2:00:00 PM
FULC,Fulcrum Therapeutics to Participate in Upcoming Investor Conferences,2/20/2020 2:01:00 PM
FULC,Fulcrum Therapeutics: FDA Grants Orphan Drug Designation To Losmapimod ,1/29/2020 2:20:45 PM
FULC,"Fulcrum Therapeutics (FULC) Up 65% In A Month, IPO Lockup Expires On Jan.14 ",1/9/2020 8:44:55 AM
FULC,Fulcrum Therapeutics Appoints Katina Dorton to its Board of Directors,1/6/2020 1:00:00 PM
FULC,Healthcare IPOs That Disappointed Investors In 2019 ,12/23/2019 10:37:24 AM
FULC,Fulcrum Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference,12/2/2019 4:37:08 PM
FULC,Fulcrum Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights,11/14/2019 1:00:00 PM
FULC,Fulcrum Therapeutics to Present at the Stifel 2019 Healthcare Conference,11/13/2019 2:01:00 PM
FULC,"Today's Top 5 Gainers In Healthcare Sector (CABA, INMD, AQST…) ",11/12/2019 3:22:16 AM
FULC,"Fulcrum Therapeutics to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019",11/6/2019 2:01:00 PM
FULC,"Fulcrum Therapeutics to Host Key Opinion Leader Breakfast Symposium on Facioscapulohumeral Dystrophy (FSHD), on November 7, 2019",10/31/2019 1:00:05 PM
FULC,"Healthcare Stocks That Plunged To New Lows(AEZS,SRNE,TROV...) ",10/10/2019 12:59:34 PM
FULC,Fulcrum Therapeutics Announced Results of Phase 1 Clinical Trial of Losmapimod in FSHD,10/4/2019 10:30:00 AM
FULC,Fulcrum Therapeutics Announces Multiple Presentations of Losmapimod Data at World Muscle Society Meeting,10/1/2019 1:00:00 PM
FULC,"Fulcrum Therapeutics Appoints Pamela Strode, Seasoned Industry Executive, to Lead Regulatory Affairs Team",9/4/2019 1:00:00 PM
FULC,Fulcrum Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference,9/3/2019 10:01:00 PM
FULC,Fulcrum Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights,8/26/2019 1:00:00 PM
FULC,"5 Top Gainers In Healthcare Sector (TROV, FULC, ARDX…) ",8/20/2019 3:29:49 AM
FULC,"Fulcrum Therapeutics Announces Initiation of ReDUX4, a Phase 2b Clinical Trial of Losmapimod for FSHD",8/19/2019 1:00:00 PM
FULC,Fulcrum Therapeutics to Present at the SVB Leerink Spotlight Series: Rare & Genetic Diseases Conference,8/1/2019 10:01:00 PM
